Compare AERO & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AERO | PBH |
|---|---|---|
| Founded | 1934 | 1996 |
| Country | Mexico | United States |
| Employees | 17068 | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.3B |
| IPO Year | N/A | 2004 |
| Metric | AERO | PBH |
|---|---|---|
| Price | $18.00 | $47.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | $28.57 | ★ $75.33 |
| AVG Volume (30 Days) | 171.0K | ★ 715.4K |
| Earning Date | 04-21-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.91 |
| Revenue | N/A | ★ $975,777,000.00 |
| Revenue This Year | $11.85 | N/A |
| Revenue Next Year | $4.57 | $4.31 |
| P/E Ratio | ★ $7.95 | $12.28 |
| Revenue Growth | N/A | ★ 36.77 |
| 52 Week Low | $12.26 | $42.62 |
| 52 Week High | $23.05 | $80.69 |
| Indicator | AERO | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 61.43 | 47.65 |
| Support Level | $17.71 | $44.86 |
| Resistance Level | $18.55 | $49.51 |
| Average True Range (ATR) | 0.81 | 1.79 |
| MACD | 0.05 | 0.38 |
| Stochastic Oscillator | 71.97 | 51.01 |
Grupo Aeromexico SAB de CV engages in providing air transport services for passengers, goods, and cargo, as well as loyalty program services, training and management services, franchise systems commercialization, and the management of investment in shares. Its services include passenger and cargo transportation, the Club Premier loyalty program, training, charter services, and other aviation-related activities. The company operates through a single operating segment, air transportation, and its geographical presence includes both domestic and international markets, with the majority of revenue coming from the international market.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.